Literature DB >> 18080351

Assessment of adherence to product dosing in a pilot microbicide study.

Kathleen Hogarty1, Andrea Kasowitz, Betsy C Herold, Marla J Keller.   

Abstract

OBJECTIVES: To determine whether applicator staining could be incorporated into a microbicide study as a marker of adherence. GOAL: To test whether observers could identify intravaginally inserted applicators and compare the observers' ratings to subjects' self reports. STUDY
DESIGN: Subjects participating in a 14-day microbicide trial to assess the safety of 0.5% PRO 2000 or matched placebo gel returned used and unused applicators. Each applicator was individually dyed or batched and immersed in a 0.4% trypan blue waterbath. Masked observers rated the applicators as intravaginally inserted or not; results were compared to subjects' self-reports. To determine if the dye would allow observers to differentiate whether applicators had been filled before intravaginal insertion, staff either filled applicators and discarded gel ex vivo or asked volunteers to intravaginally insert applicators without gel and mixed these with a random sampling of used and unused study samples.
RESULTS: 358 of 360 applicators were returned; 306 were reported to have been vaginally inserted and 52 unused. Observers agreed with the participant's self reports in 98-99% of cases. No differences were observed between applicators stained individually or in batches. The ability to distinguish between applicators that were presumed to have been used properly, intravaginally inserted without gel, filled with gel and emptied ex vivo, or unused ranged from 76 to 87%.
CONCLUSIONS: Staining of applicators is accurate, inexpensive, and correlated well with self-report in a study of short duration. This method could prove useful in assessing adherence to product dosing in future microbicide trials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18080351

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  9 in total

Review 1.  Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research.

Authors:  Michael J Stirratt; Christopher M Gordon
Journal:  Curr HIV/AIDS Rep       Date:  2008-11       Impact factor: 5.071

Review 2.  Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies.

Authors:  Q Abdool Karim; C Baxter; S Abdool Karim
Journal:  BJOG       Date:  2014-10       Impact factor: 6.531

3.  Validation of a dye stain assay for vaginally inserted hydroxyethylcellulose-filled microbicide applicators.

Authors:  Lauren L Katzen; José A Fernández-Romero; Avina Sarna; Kailapuri G Murugavel; Daniel Gawarecki; Thomas M Zydowsky; Barbara S Mensch
Journal:  Sex Transm Dis       Date:  2011-11       Impact factor: 2.830

4.  Trypan blue staining to determine vaginal exposure in two types of plastic vaginal applicators containing two different microbicide formulations.

Authors:  Anke Hemmerling; William G Harrison; Joelle Morgan Brown; Barbara Moscicki; Maria Oziemkowska; Elizabeth A Bukusi; Craig R Cohen
Journal:  Sex Transm Dis       Date:  2012-09       Impact factor: 2.830

5.  Measuring adherence by visual inspection of returned empty gel applicators in the CAPRISA 004 microbicide trial.

Authors:  Tanuja N Gengiah; Leila E Mansoor; Michele Upfold; Anushka Naidoo; Nonhlanhla Yende-Zuma; Angela D M Kashuba; Quarraisha Abdool Karim; Salim S Abdool Karim
Journal:  AIDS Behav       Date:  2014-05

6.  Use of the dye stain assay and ultraviolet light test for assessing vaginal insertion of placebo-filled applicators before and after sex.

Authors:  Marla J Keller; Niall Buckley; Lauren L Katzen; Jennifer Walsh; Barbara Friedland; Sarah Littlefield; Juan Lin; Xiaonan Xue; Terri Cornelison; Betsy C Herold; Mark H Einstein
Journal:  Sex Transm Dis       Date:  2013-12       Impact factor: 2.830

7.  Limitations of the dye-based method for determining vaginal applicator use in microbicide trials.

Authors:  Michele N Austin; Lorna K Rabe; Sharon L Hillier
Journal:  Sex Transm Dis       Date:  2009-06       Impact factor: 2.830

8.  Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive.

Authors:  Marla J Keller; Colleen A Carpenter; Yungtai Lo; Mark H Einstein; Congzhou Liu; David N Fredricks; Betsy C Herold
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

9.  A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel.

Authors:  Marla J Keller; Rebecca P Madan; N Merna Torres; Melissa J Fazzari; Sylvia Cho; Sabah Kalyoussef; Gail Shust; Pedro M M Mesquita; Nicolette Louissaint; Jianmeng Chen; Hillel W Cohen; Erin C Diament; Anna C Lee; Lydia Soto-Torres; Craig W Hendrix; Betsy C Herold
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.